Petur Snaebjornsson

22PUBLICATIONS
134CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Mar 21, 2026
Real-world clinical utility of tumor whole-genome sequencing in solid cancers.

Jeffrey van Putten, Petur Snaebjornsson, Linda J W Bosch

|Mar 13, 2025
Real-world treatment patterns and outcomes based on RAS/BRAF status in metastatic colorectal cancer-Analysis of the Prospective Dutch Colorectal Cancer cohort.

Sietske C M W van Nassau, Koen Zwart, Frederieke H van der Baan

|Nov 14, 2024
Platinum retention in plasma, urine, and normal colonic mucosa in cisplatin-treated testicular cancer survivors.

Emilie C H Breekveldt, Berbel L M Ykema, Alwin D R Huitema

|May 20, 2024
Efficacy-effectiveness analysis on survival in a population-based real-world study of BRAF-mutated metastatic colorectal cancer patients treated with encorafenib-cetuximab.

Koen Zwart, Sietske C M W van Nassau, Frederieke H van der Baan

|May 15, 2024
Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.

Birgit S Geurts, Laurien J Zeverijn, Jade M van Berge Henegouwen

|Mar 27, 2024
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy.

Matheus Henrique Dias, Anoek Friskes, Siying Wang

Pageof 4

Frequent Collaborators

5 joint publications

Monique van Leerdam

4 joint publications

Berbel L M Ykema

3 joint publications

Emile E Voest

2 joint publications

Kim Monkhorst